David Barack is a philosopher and neuroscientist who studies the neural circuits of foraging behavior and the conceptual foundations of cognitive neuroscience. He is a postdoctoral researcher at the University of Pennsylvania. After earning his B.A. in consciousness studies at Pitzer College, he received his M.A. in philosophy from the University of Wisconsin-Milwaukee and his Ph.D. in philosophy from Duke University, where he also received a certificate in cognitive neuroscience. He is currently writing a book on the neurodynamical foundations of mind.
David Barack
Research associate in neuroscience and philosophy
University of Pennsylvania
From this contributor
Must a theory be falsifiable to contribute to good science?
Four researchers debate the role that non-testable theories play in neuroscience.
Must a theory be falsifiable to contribute to good science?
By
Grace Lindsay, moderator
10 June 2024 | 55 min read
Explore more from The Transmitter
Supported by a $40 million NIH grant, Yale brain shuttle technology raises questions
Yale University claims its STEP platform might be able to deliver gene-editing tools into the brain via multiple routes. Researchers are eager to see more.
Supported by a $40 million NIH grant, Yale brain shuttle technology raises questions
Yale University claims its STEP platform might be able to deliver gene-editing tools into the brain via multiple routes. Researchers are eager to see more.
By
Natalia Mesa
3 June 2026 | 11 min read
What counts as a ‘naturalistic’ behavior?
Nedah Nemati explains how neuroscience methods and the lived experience of the scientists themselves shape how we define the behaviors we seek to explain.
What counts as a ‘naturalistic’ behavior?
Nedah Nemati explains how neuroscience methods and the lived experience of the scientists themselves shape how we define the behaviors we seek to explain.
By
Paul Middlebrooks
3 June 2026 | 1 min read
Allen Institute sets sights on treatments for five brain diseases
The Brain Health Accelerator program aims to harness single-cell transcriptomics and cell-type-specific genetic tools to develop treatments for Alzheimer’s, Huntington’s and Parkinson’s diseases, Lewy body dementia and ALS.
Allen Institute sets sights on treatments for five brain diseases
The Brain Health Accelerator program aims to harness single-cell transcriptomics and cell-type-specific genetic tools to develop treatments for Alzheimer’s, Huntington’s and Parkinson’s diseases, Lewy body dementia and ALS.
By
Calli McMurray
2 June 2026 | 5 min read